View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorised
May 15, 2020

Hologic receives EUA for Covid-19 assay

By Chloe Kent

Hologic has received Emergency Use Authorisation (EUA) from the US Food and Drug Administration (FDA) for its Aptima SARS-CoV-2 assay.

The antigen test runs on Hologic’s fully automated Panther system, which can provide initial results within three hours and carry out over 1,000 Covid-19 tests within a 24-hour period.

The test was the first Covid-19 diagnostic to receive R&D support from the US government Biomedical Advanced Research and Development Authority (BARDA), receiving nearly $700,000 in funding.

Hologic plans to register its Aptima SARS-CoV-2 assay for a CE Mark for diagnostic use in Europe later in May.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network